New Talent Is In At Sanofi, Biogen
This article was originally published in The Pink Sheet Daily
Sanofi appointed immunology expert Yong-Jun Liu as head of research, leaving a vacancy at Medimmune, while Biogen recruited its new chief commercial officer Michel Vounatsos from Merck.
You may also be interested in...
Elias Zerhouni says Sanofi's ongoing R&D revamp has produced improved innovative results with controlled spending, in part by emphasizing cutting-edge product development ahead of research.
Orna is retaining full ownership of its "crown jewel," in situ CAR programs for cancer. CEO Tom Barnes talked to Scrip about the deal and Orna's business strategy.
The pediatric market represents 70%-75% of the market for pneumococcal vaccines; Merck & Co.'s Vaxneuvance was already approved for infants earlier this year.